These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 12431498)

  • 1. Activity of disinfectants against Gram-negative bacilli isolated from patients undergoing lung transplantation for cystic fibrosis.
    Perry JD; Riley G; Johnston S; Dark JH; Gould FK
    J Heart Lung Transplant; 2002 Nov; 21(11):1230-1. PubMed ID: 12431498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The rate of antimicrobial action of noxythiolin and taurolin.
    Brearley S; George RH
    J Hosp Infect; 1980 Sep; 1(3):201-9. PubMed ID: 6182213
    [No Abstract]   [Full Text] [Related]  

  • 3. [Bactericial activity of chlorhexidine gluconate against recent clinical isolates of various bacterial species in Japan].
    Kanazawa K; Ueda Y
    Jpn J Antibiot; 2004 Oct; 57(5):449-64. PubMed ID: 15655906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of doripenem against Pseudomonas aeruginosa and Burkholderia cepacia isolates from both cystic fibrosis and non-cystic fibrosis patients.
    Traczewski MM; Brown SD
    Antimicrob Agents Chemother; 2006 Feb; 50(2):819-21. PubMed ID: 16436756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of taurolidine, chlorophenol-camphor-menthol and chlorhexidine against oral pathogenic microorganisms.
    Zimmermann M; Preac-Mursic V
    Arzneimittelforschung; 1992 Sep; 42(9):1157-9. PubMed ID: 1445486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of panresistant bacteria in cystic fibrosis patients on lung transplant outcome.
    Aris RM; Gilligan PH; Neuringer IP; Gott KK; Rea J; Yankaskas JR
    Am J Respir Crit Care Med; 1997 May; 155(5):1699-704. PubMed ID: 9154879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained anti-adherence activity of taurolidine (Taurolin) and noxythiolin (Noxyflex S) solutions.
    Blenkharn JI
    J Pharm Pharmacol; 1988 Jul; 40(7):509-11. PubMed ID: 2904994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-vitro antibacterial activity of noxythiolin and taurolidine.
    Blenkharn JI
    J Pharm Pharmacol; 1990 Aug; 42(8):589-90. PubMed ID: 1981591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of taurolidine in lung transplantation for cystic fibrosis and impact on bacterial colonization.
    Zeriouh M; Sabashnikov A; Patil NP; Schmack B; Zych B; Mohite PN; García Sáez D; Koch A; Mansur A; Soresi S; Weymann A; Marczin N; Wahlers T; De Robertis F; Simon AR; Popov AF
    Eur J Cardiothorac Surg; 2018 Mar; 53(3):603-609. PubMed ID: 29048473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pseudomonas cepacia empyema necessitatis after lung transplantation in two patients with cystic fibrosis.
    Noyes BE; Michaels MG; Kurland G; Armitage JM; Orenstein DM
    Chest; 1994 Jun; 105(6):1888-91. PubMed ID: 7515778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pseudomonas cepacia in lung transplant recipients with cystic fibrosis.
    Snell GI; de Hoyos A; Krajden M; Winton T; Maurer JR
    Chest; 1993 Feb; 103(2):466-71. PubMed ID: 7679347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Taurolin as an oral rinse. I. Antimicrobial effects in vitro and in vivo.
    Reynolds S; Moran J; Addy M; Wade WG; Newcombe R
    Clin Prev Dent; 1991; 13(2):13-7. PubMed ID: 1860285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of resistance to chlorhexidine diacetate in Pseudomonas aeruginosa and the effect of a "residual" concentration.
    Thomas L; Maillard JY; Lambert RJ; Russell AD
    J Hosp Infect; 2000 Dec; 46(4):297-303. PubMed ID: 11170761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimating in vivo airway surface liquid concentration in trials of inhaled antibiotics.
    Hasan MA; Lange CF
    J Aerosol Med; 2007; 20(3):282-93. PubMed ID: 17894535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of pan-resistant bacterial pathogens on survival after lung transplantation in cystic fibrosis: results from a single large referral centre.
    Dobbin C; Maley M; Harkness J; Benn R; Malouf M; Glanville A; Bye P
    J Hosp Infect; 2004 Apr; 56(4):277-82. PubMed ID: 15066737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Minimal inhibitory and bactericidal concentrations of some antiseptics and disinfectants against strains of hospital origin].
    Fernández-Crehuet Navajas R; Merina Díaz R; Serrano del Castillo A; Iribarren Marín MA
    Rev Latinoam Microbiol; 1992; 34(1):1-6. PubMed ID: 1345297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival of lung transplant patients with cystic fibrosis harboring panresistant bacteria other than Burkholderia cepacia, compared with patients harboring sensitive bacteria.
    Hadjiliadis D; Steele MP; Chaparro C; Singer LG; Waddell TK; Hutcheon MA; Davis RD; Tullis DE; Palmer SM; Keshavjee S
    J Heart Lung Transplant; 2007 Aug; 26(8):834-8. PubMed ID: 17692788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial activity of superoxidized water.
    Tanaka H; Hirakata Y; Kaku M; Yoshida R; Takemura H; Mizukane R; Ishida K; Tomono K; Koga H; Kohno S; Kamihira S
    J Hosp Infect; 1996 Sep; 34(1):43-9. PubMed ID: 8880549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A simple method for the evaluation of antiseptic and disinfectant virucidal activity.
    Boudouma M; Enjalbert L; Didier J
    J Virol Methods; 1984 Dec; 9(4):271-6. PubMed ID: 6099370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiresistant non-fermentative gram-negative bacteria in cystic fibrosis patients: the results of an Italian multicenter study. Italian Group for Cystic Fibrosis microbiology.
    Taccetti G; Campana S; Marianelli L
    Eur J Epidemiol; 1999 Jan; 15(1):85-8. PubMed ID: 10099000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.